The inquiry stems from a September 11, 2026, research note by UBS analyst Jon Windham, who downgraded the stock from neutral to sell. Windham slashed the price target to $6, citing a critical erosion of NuScale’s first-mover advantage. The report highlighted a five-year construction timeline and a lack of firm customer commitments, warning that the company faces approximately $700 million in negative free cash flow through 2028. Analysts also pointed to stalled progress on the flagship RoPower project in Romania and the company’s partnership with the Tennessee Valley Authority.
Investors who suffered losses following the stock's slide to $8.61 are being urged to contact Danielle Peyton at Pomerantz LLP. While the firm, which operates globally, has a history of litigating securities and antitrust cases, this investigation remains in the early stages as legal counsel evaluates whether the company’s disclosures adequately reflected its operational headwinds.


Comments (0)
No comments yet. Be the first!